Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S356100, C548S371400, C548S371700, C548S146000, C548S161000, C514S367000, C514S403000, C514S406000
Reexamination Certificate
active
07902248
ABSTRACT:
Disclosed herein are pyrazole glucokinase activators of the formula (I):that are useful for the treatment of metabolic diseases and disorders.
REFERENCES:
patent: 6353111 (2002-03-01), Corbett et al.
patent: 6951945 (2005-10-01), Bizzarro et al.
patent: 7132425 (2006-11-01), Chen et al.
patent: 7259166 (2007-08-01), Corbett et al.
patent: 7514439 (2009-04-01), Sugawara et al.
patent: 2004/0138465 (2004-07-01), Spurr
patent: 4426940 (1996-01-01), None
patent: 19925780 (2000-02-01), None
patent: 282971 (1994-12-01), None
patent: WO 9526956 (1995-10-01), None
patent: WO 9623763 (1996-08-01), None
patent: WO 9700866 (1997-01-01), None
patent: WO 2001044216 (2001-06-01), None
patent: WO 2002008209 (2002-01-01), None
patent: WO 2002014312 (2002-02-01), None
patent: WO 2004052869 (2004-06-01), None
patent: WO 2004058724 (2004-07-01), None
patent: WO 2004063179 (2004-07-01), None
patent: WO 2004063194 (2004-07-01), None
patent: WO 2004072031 (2004-08-01), None
patent: WO 2004072066 (2004-08-01), None
patent: WO 2005023761 (2005-03-01), None
patent: WO 2005103021 (2005-11-01), None
patent: WO 2006016194 (2006-02-01), None
patent: WO 2007007886 (2007-01-01), None
patent: WO 2007026761 (2007-03-01), None
patent: WO 2007058990 (2007-05-01), None
patent: WO 2007146712 (2007-12-01), None
Komori et al (2004): STN International HCAPLUS database, (Columbus, Ohio), Accession No. 2004:162673.
Ishikawa, T.; Kamiyama,Antibiot. 2000, 53, 1071-1085.
Kai, H.; Matsumoto,Bioorg. Med. Chem. Lett. 2001, 11, 1997-2000.
Yamashita, T.;Synlett. 2003, 738-740.
Domagala,J. Org. Chem. 1981, 46, 134-140.
Yamazaki,Bioorganic&Medicinal Chemistry2005, 13, 2509-2522.
Jordan, A. D.;J. Org. Chem. 2003, 68, 8693-8696.
Johnson, F. E.; Hamilton, C. S.J. Am. Chem. Soc. 1949, 71, 74-6.
Expert Opin. Ther.Patents (2008) 18(7) p. 759.
Nippon Noyaku Gakkaishi (2000) 24-30.
Tet. Lett. 2006, 2675.
Berthel Steven Joseph
Kester Robert Francis
Murphy Douglas Eric
Prins Thomas Jay
Ruebsam Frank
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Shameem Golam M
Tramaloni Dennis P.
LandOfFree
Oxime glucokinase activators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxime glucokinase activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxime glucokinase activators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2708589